CAPR

CAPRICOR THERAPEUTICS INC

CAPR·14070B309·US·Common Stock·Healthcare - Biotechnology-13D/G

CAPR (CAPRICOR THERAPEUTICS INC) is held by 105 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($104M), STATE STREET CORP ($66.3M), VANGUARD CAPITAL MANAGEMENT LLC ($61.6M). Net institutional sentiment: Bullish.

105
Holders
Avg rating(23 Elite)
$649.1M
Total Value
72% (113)
Fund Consensus
76 buying - 30 selling
CAPRSmart Money Verdict
View all
Held by 105 funds
23 elite
Who's Trading
InsiderKKKrasney KarenExercise 25K shMay 1, 2026
InsiderBABergmann AnthonyExercise 25K shMay 1, 2026
InsiderKKKrasney KarenSell $793KMay 1, 2026
InsiderBABergmann AnthonySell $793KMay 1, 2026
InsiderSESabar Karimah EsSell $241KApr 2, 2026
InsiderSESabar Karimah EsSell $1.7MApr 1, 2026
InsiderKKKrasney KarenSell $753KMar 31, 2026
InsiderBABergmann AnthonySell $753KMar 31, 2026
ActivistSUSUVRETTA CAPITAL MANAGEMENT, LLC6.6%Feb 26, 2026
ActivistHIHighbridge Capital Management, LLC2.3%Feb 17, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.4M(+20.0%)$104M0.0%+36.60%
36
Increased
2.2M(+163.0%)$66.3M0.0%+3.48%
48
New
2M$61.6M0.0%-16.76%
41
Unchanged
1.5M$45.8M0.5%-25.73%
0
Increased
1.1M(+9.9%)$34M0.0%+108.19%
32
Increased
911,976(+103.6%)$27.7M0.0%-9.14%
46
Decreased
821,179(-55.4%)$25M0.0%-21.98%
0
Decreased
772,649(-16.3%)$23.5M0.0%-24.70%
0
New
566,081$17.2M0.0%-16.76%
39
Decreased
539,232(-40.2%)$16.4M0.0%-15.19%
0
Decreased
423,819(-27.7%)$12.9M0.0%+64.13%
0
Increased
417,543(+19.1%)$12.7M0.0%+79.09%
33
Increased
415,483(+672.0%)$12.6M0.0%-12.84%
45
New
402,999$12.3M0.0%-16.76%
39
New
379,214$11.5M0.0%-16.76%
39
Increased
371,984(+56.1%)$11.3M0.0%-2.51%
39
Decreased
356,354(-47.8%)$10.8M0.0%-6.68%
0
New
320,098$9.7M0.0%-16.76%
38
Increased
314,792(+163.7%)$9.6M0.0%-10.04%
45
Decreased
343,613(-6.9%)$9.5M0.0%+7.99%
0

Showing 1-20 of 113

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used